The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Present and future arboviral threats
Weaver, S. C., & Reisen, W. K. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.008 · Cited by 1,566
Infection with chikungunya virus in Italy: an outbreak in a temperate region
Rezza, G., Nicoletti, L., Angelini, R., Romi, R., Finarelli, A., Panning, M., Cordioli, P., Fortuna, C., Boros, S., Magurano, F., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61779-6 · Cited by 1,527
Chikungunya, an epidemic arbovirosis
Pialoux, G., Gaüzère, B.-A., Jauréguiberry, S., & Strobel, M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70107-x · Cited by 1,129
Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus
Powers, A. M., & Logue, C. H. (2007) · Journal of General Virology · doi:10.1099/vir.0.82858-0 · Cited by 822
Chikungunya Fever: An Epidemiological Review of a Re‐Emerging Infectious Disease
Staples, J. E., Breiman, R. F., & Powers, A. M. (2009) · Clinical Infectious Diseases · doi:10.1086/605496 · Cited by 735
Hoarau, J.-J., Jaffar Bandjee, M.-C., Krejbich Trotot, P., Das, T., Li-Pat-Yuen, G., Dassa, B., Denizot, M., Guichard, E., Ribera, A., Henni, T., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900255 · Cited by 640
Leparc-Goffart, I., Nougairede, A., Cassadou, S., Prat, C., & de Lamballerie, X. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60185-9 · Cited by 559
Akahata, W., Yang, Z.-Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W.-P., Lewis, M. G., Higgs, S., Rossmann, M. G., Rao, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2105 · Cited by 515
Self-citationChow, A., Her, Z., Ong, E. K. S., Chen, J.-M., Dimatatac, F., Kwek, D. J. C., Barkham, T., Yang, H., Rénia, L., Leo, Y.-S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq042 · Cited by 389
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
Pal, P., Dowd, K. A., Brien, J. D., Edeling, M. A., Gorlatov, S., Johnson, S., Lee, I., Akahata, W., Nabel, G. J., Richter, M. K. S., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003312 · Cited by 300
Self-citation
Cited by
Epidemic arboviral diseases: priorities for research and public health
Wilder-Smith, A., Gubler, D. J., Weaver, S. C., Monath, T. P., Heymann, D. L., & Scott, T. W. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30518-7 · Cited by 573
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.014 · Cited by 555
The neurological complications of chikungunya virus: A systematic review
Mehta, R., Gerardin, P., de Brito, C. A. A., Soares, C. N., Ferreira, M. L. B., & Solomon, T. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1978 · Cited by 258
Structure-Based Vaccine Antigen Design
Graham, B. S., Gilman, M. S. A., & McLellan, J. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-121217-094234 · Cited by 234
Self-citationCOVID-19 vaccines: breaking record times to first-in-human trials
Kim, Y. C., Dema, B., & Reyes-Sandoval, A. (2020) · npj Vaccines · doi:10.1038/s41541-020-0188-3 · Cited by 117
Metadata
- Authors
- Chang, L.-J., Dowd, K. A., Mendoza, F. H., Saunders, J. G., Sitar, S., Plummer, S. H., Yamshchikov, G., Sarwar, U. N., Hu, Z., Enama, M. E., Bailer, R. T., Koup, R. A., Schwartz, R. M., Akahata, W., Nabel, G. J., Mascola, J. R., Pierson, T. C., Graham, B. S., & Ledgerwood, J. E.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 384
- Issue
- 9959
- Pages
- 2046-2052
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2160743148
- Cited by
- 257
- References
- 29
- FWCI
- 30.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. https://app.cochat.ai/papers/10.1016/s0140-6736(14)61185-5
- The paper
- Chang, L.-J., Dowd, K. A., Mendoza, F. H., Saunders, J. G., Sitar, S., Plummer, S. H., Yamshchikov, G., Sarwar, U. N., Hu, Z., Enama, M. E., Bailer, R. T., Koup, R. A., Schwartz, R. M., Akahata, W., Nabel, G. J., Mascola, J. R., Pierson, T. C., Graham, B. S., & Ledgerwood, J. E. (2014). Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. The Lancet. https://doi.org/10.1016/s0140-6736(14)61185-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
